Cell biology, Immunology, Phosphorylation, Protein kinase B and Francisella are his primary areas of study. His study ties his expertise on Biochemistry together with the subject of Cell biology. Susheela Tridandapani has researched Phosphorylation in several fields, including Receptor, Tyrosine and Signal transduction.
His research integrates issues of Macrophage, Cell cycle and Kinase in his study of Protein kinase B. Within one scientific family, he focuses on topics pertaining to CD52 under Chronic lymphocytic leukemia, and may sometimes address concerns connected to Cancer research. His study looks at the relationship between PI3K/AKT/mTOR pathway and topics such as Inflammation, which overlap with Monocyte.
Susheela Tridandapani mainly focuses on Cell biology, Immunology, Cancer research, Monocyte and Cytokine. His Cell biology research focuses on subjects like Receptor, which are linked to Myeloid. His research in Cancer research intersects with topics in Bruton's tyrosine kinase, Interleukin 21, Lymphokine-activated killer cell and Ibrutinib.
Susheela Tridandapani works mostly in the field of Protein kinase B, limiting it down to topics relating to PI3K/AKT/mTOR pathway and, in certain cases, MAPK/ERK pathway, Kinase and Molecular biology, as a part of the same area of interest. His Phosphorylation research incorporates elements of Tyrosine and Transfection. His Immune system research includes elements of Cancer cell and Microbiology.
Susheela Tridandapani spends much of his time researching Cancer research, Immunology, Cytokine, Monocyte and Immunotherapy. Susheela Tridandapani combines subjects such as Bruton's tyrosine kinase, Leukemia, Ibrutinib and Lymphokine-activated killer cell with his study of Cancer research. In his study, Interferon, CD86 and Cancer is inextricably linked to Fc receptor, which falls within the broad field of Cytokine.
The Monocyte study combines topics in areas such as Interferon gamma and Cell biology. Susheela Tridandapani is involved in the study of Cell biology that focuses on Phagocytosis in particular. His work deals with themes such as CCL2, In vitro, Adverse effect, Innate immune system and Antibody, which intersect with Immunotherapy.
Susheela Tridandapani mainly investigates Cancer research, Immunology, Cytokine, Myeloid-derived Suppressor Cell and Immunotherapy. His Cancer research research is multidisciplinary, relying on both Oncology, Natural killer cell, Interleukin 21, Lymphokine-activated killer cell and Chemokine. The various areas that Susheela Tridandapani examines in his Immunology study include Tyrosine kinase and Bruton's tyrosine kinase.
His research integrates issues of Cancer, Receptor, Fc receptor, Adoptive cell transfer and Monocyte in his study of Cytokine. The various areas that Susheela Tridandapani examines in his Immunotherapy study include Gastroenterology, Adverse effect, Alpha interferon and Vaccination. His Immune system research incorporates elements of Cancer cell and Stromal cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Macrophage microvesicles induce macrophage differentiation and miR-223 transfer.
Noura Ismail;Yijie Wang;Duaa Dakhlallah;Leni Moldovan.
Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating akt and p38 mAPK
Nathan M. Weir;Karuppaiyah Selvendiran;Vijay Kumar Kutala;Liyue Tong.
Cancer Biology & Therapy (2007)
Regulated Expression and Inhibitory Function of FcγRIIb in Human Monocytic Cells
Susheela Tridandapani;Kristina Siefker;Jean-Luc Teillaud;Jo Ellen Carter.
Journal of Biological Chemistry (2002)
Negative signaling in B lymphocytes induces tyrosine phosphorylation of the 145-kDa inositol polyphosphate 5-phosphatase, SHIP.
G W Chacko;S Tridandapani;J E Damen;L Liu.
Journal of Immunology (1996)
Caspase-7 Activation by the Nlrc4/Ipaf Inflammasome Restricts Legionella pneumophila Infection
Anwari Akhter;Mikhail A. Gavrilin;Laura Frantz;Songcerae Washington.
PLOS Pathogens (2009)
miR-155 regulates IFN-γ production in natural killer cells.
Rossana Trotta;Li Chen;David Ciarlariello;Srirama Josyula.
MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response.
Thomas J. Cremer;David H Ravneberg;Corey D. Clay;Melissa G. Piper-Hunter.
PLOS ONE (2009)
Pulmonary Surfactant Protein A Regulates TLR Expression and Activity in Human Macrophages
Lisa N. Henning;Abul K. Azad;Kishore V. L. Parsa;Joy E. Crowther.
Journal of Immunology (2008)
Lipopolysaccharide-Induced Macrophage Inflammatory Response Is Regulated by SHIP
Huiqing Fang;Ruma A. Pengal;Xianhua Cao;Latha P. Ganesan.
Journal of Immunology (2004)
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical
Xiaobin B Zhao;Rosa Lapalombella;Trupti Joshi;Carolyn Cheney.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: